Ministry Of Health 3
101. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c
102. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c
103. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c
104. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c
105. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c
106. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c
107. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c
108. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c
109. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c
110. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c
111. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
112. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
113. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
114. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
115. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
116. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
117. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
118. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
119. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
120. Evaluation of a national framework for rational use of medicines in Kazakhstan and its role in improving medicine use practices at the organizational and national levels
121. World Tuberculosis Day 2021 Theme — ‘The Clock is Ticking’ — and the world is running out of time to deliver the United Nations General Assembly commitments to End TB due to the COVID-19 pandemic
122. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
1 2 3 3